Buscar
Mostrando ítems 11-20 de 501
In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species
(Wiley, 2013-04)
The strict nutritional requirements of Malassezia species make it difficult to test the antifungal susceptibility. Treatments of the chronic and recurrent infections associated with Malassezia spp. are usually ineffective. ...
Alterations in growth and branching of Neurospora crassa caused by sub-inhibitory concentrations of antifungal agents
(ASOCIACION ARGENTINA MICROBIOLOGIA, 2009)
Six antifungal agents at subinhibitory concentrations were used for investigating their ability to affect the growth and branching in Neurospora crassa. Among the antifungals herein used, the azole agent ketoconazole at ...
In vitro antifungal susceptibility of Candida spp. isolates from patients with chronic periodontitis and from control patients
(2004-01-01)
Superinfection by Candida can be refractory to conventional periodontal treatments in specific situations, such as in immunocompromised patients. In these cases, the systemic therapy with antifungal drugs could be indicated. ...
Fusariosis in an immunocompromised patient: therapeutic success with voriconazole
(SOC BRASILEIRA DERMATOLOGIA, 2008)
Fusarium infection is known to be potentially severe in immunocompromised patients, especially those with hematologic malignancies. Mortality rates are high and there are few therapeutic options, due to the severe underlying ...
CANDIDIASE EM PACIENTES AIDETICOS
(1992-12-01)
Disseminated Amphotericin-Resistant Fusariosis in Acute Leukemia Patients: Report of Two Cases
(2013-01-01)
Disseminated fusariosis has emerged as a significant, usually fatal infection in immunocompromised hosts despite antifungal treatment. We describe here two patients with acute leukemia who developed disseminated ...
Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis
(Expert Reviews, 2013-02)
Sertaconazole is a useful antifungal agent against mycoses of the skin and mucosa, such as cutaneous, genital and oral candidiasis and tinea pedis. Its antifungal activity is due to inhibition of the ergosterol biosynthesis ...
Potential Use of Phenolic Acids as Anti-Candida Agents: A Review
(Frontiers Media Sa, 2015-12-21)
There has been a sharp rise in the occurrence of Candida infections and associated mortality over the last few years, due to the growing body of immunocompromised population. Limited number of currently available antifungal ...